Epidemiology of myelin oligodendrocyte glycoprotein antibody-associated disease: a review of prevalence and incidence worldwide
JY Hor, K Fujihara - Frontiers in Neurology, 2023 - frontiersin.org
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is an
inflammatory demyelinating disease of the central nervous system (CNS) with the presence …
inflammatory demyelinating disease of the central nervous system (CNS) with the presence …
Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease
Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) is a spectrum of diseases,
including optic neuritis, transverse myelitis, acute disseminated encephalomyelitis, and …
including optic neuritis, transverse myelitis, acute disseminated encephalomyelitis, and …
Diagnostic implications of MOG-IgG detection in sera and cerebrospinal fluids
Y Matsumoto, K Kaneko, T Takahashi, Y Takai… - Brain, 2023 - academic.oup.com
The spectrum of MOG-IgG-associated disease (MOGAD) includes optic neuritis (ON),
myelitis (MY), acute disseminated encephalomyelitis (ADEM), brainstem encephalitis …
myelitis (MY), acute disseminated encephalomyelitis (ADEM), brainstem encephalitis …
MOG CNS Autoimmunity and MOGAD
CE Moseley, A Virupakshaiah… - Neurology …, 2024 - neurology.org
At one time considered a possible form of neuromyelitis optica (NMO) spectrum disorder
(NMOSD), it is now accepted that myelin oligodendrocyte glycoprotein (MOG) antibody (Ab) …
(NMOSD), it is now accepted that myelin oligodendrocyte glycoprotein (MOG) antibody (Ab) …
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): current understanding and challenges
A Al-Ani, JJ Chen, F Costello - Journal of Neurology, 2023 - Springer
New diagnostic criteria for myelin oligodendrocyte glycoprotein antibody-associated disease
(MOGAD) have recently been proposed, distinguishing this syndrome from other …
(MOGAD) have recently been proposed, distinguishing this syndrome from other …
Diagnostic Utility of MOG Antibody Testing in Cerebrospinal Fluid
V Redenbaugh, JP Fryer, L Cacciaguerra… - Annals of …, 2024 - Wiley Online Library
Objective The aim of this study was to assess the diagnostic utility of cerebrospinal fluid
(CSF) myelin oligodendrocyte glycoprotein antibodies (MOG‐IgG) testing. Methods We …
(CSF) myelin oligodendrocyte glycoprotein antibodies (MOG‐IgG) testing. Methods We …
The influence of MOGAD on diagnosis of multiple sclerosis using MRI
R Geraldes, G Arrambide, B Banwell, À Rovira… - Nature Reviews …, 2024 - nature.com
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is an
immune-mediated demyelinating disease that is challenging to differentiate from multiple …
immune-mediated demyelinating disease that is challenging to differentiate from multiple …
[HTML][HTML] MOGAD: A comprehensive review of clinicoradiological features, therapy and outcomes in 4699 patients globally
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is one of the
most common antibody-mediated CNS disorders. Optimal diagnostic and prognostic …
most common antibody-mediated CNS disorders. Optimal diagnostic and prognostic …
The clinical relevance of MOG antibody testing in cerebrospinal fluid
M Reynolds, I Tan, K Nguyen, V Merheb… - Annals of clinical …, 2024 - Wiley Online Library
Myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD) is diagnosed
by serum MOG‐immunoglobulin G (MOG‐IgG) in association with typical demyelination …
by serum MOG‐immunoglobulin G (MOG‐IgG) in association with typical demyelination …
Investigating the 2023 MOGAD criteria in children and adults with MOG-antibody positivity within and outside attacks
E Fonseca, G Olivé-Cirera, E Martinez-Hernandez… - Neurology, 2024 - neurology.org
Background and Objectives The 2023 criteria for myelin oligodendrocyte glycoprotein
antibody-associated disease (MOGAD) perform well in adults but have not been assessed in …
antibody-associated disease (MOGAD) perform well in adults but have not been assessed in …